Related Experiment Videos
Increased Fas antigen on T cells in multiple sclerosis
1Department of Neurology, Tokyo Women's Medical College, Japan.
Journal of Neuroimmunology
|December 1, 1996
Summary
Programmed cell death, or apoptosis, of T cells may drive multiple sclerosis (MS). Research found higher Fas antigen expression in MS patients, suggesting altered T cell apoptosis in this autoimmune disease.
Area of Science:
- Immunology
- Neuroscience
- Cell Biology
Background:
- Programmed cell death, specifically apoptosis, of antigen-specific T cells is implicated in autoimmune diseases like multiple sclerosis (MS).
- Fas antigen is a key molecule associated with apoptosis.
- Understanding T cell apoptosis in MS is crucial for disease pathogenesis research.
Purpose of the Study:
- To investigate the role of Fas antigen in the pathogenesis of multiple sclerosis (MS).
- To measure and compare the expression of Fas antigen and T cell activation markers in MS patients and healthy controls.
Main Methods:
- Flow cytometry was used to quantify Fas antigen and activation marker expression on T cells.
- Samples were analyzed from peripheral blood (PB) of 19 MS patients and 18 controls.
- Cerebrospinal fluid (CSF) samples from nine MS patients were also analyzed.
Main Results:
- The expression rate of Fas antigen was significantly higher in the peripheral blood of MS patients compared to healthy controls.
- In MS patients, both Fas antigen and T cell activation marker expression rates were elevated in cerebrospinal fluid compared to peripheral blood.
- These findings indicate altered apoptosis dynamics in activated T cells within the central nervous system of MS patients.
Conclusions:
- The study suggests an acceleration or impairment of apoptosis in activated T cells is associated with multiple sclerosis.
- Elevated Fas antigen expression in MS patients points to its potential role in the disease's autoimmune mechanisms.
- Findings highlight the importance of T cell apoptosis dysregulation in the context of MS pathogenesis.